suggested that cell-cell interactions might also be required. In the present study, we show that cognate T/B cell recognition via MHC class II antigens and the TCR/CD3 complex is necessary for IL-4-dependent IgE synthesis to proceed . Accessory adhesion molecules expressed on B and/or T cells also contribute to the cellular interactions required for IgE synthesis .
Materials and Methods
in Results . In some experiments, purified B cells were incubated with supernatants from cultures of T cells or T+B cells (1 .5 x 10 6 cells/ml, 2 :1 ratio) stimulated for 48 h with rIL-4 (100 U/ml) . Insolubilized anti-A antibodies (1-10 pg/ml) or SAC (0.1% ; The Enzyme Center Inc ., Malden, MA) were added to cultures of purified B cells in other experiments . Autologous T/B cell mixtures (1 .5 x 106 cells/ml) were cultured under the same conditions . In some experiments, autologous purified T and B cells were separated during culture by a 0 .4 Am membrane using well inserts (Millicell-HA, Millipore Corp ., Bedford, MA) . After 9 d, the culture supernatants were harvested and assessed by RIA for their IgE content . Control cultures for the evaluation of preformed IgE were set up in the presence of cycloheximide (100 Wg/ml ; Sigma Chemical Co.) . Net IgE synthesis was evaluated by subtracting the IgE concentrations detected in cycloheximide-treated cultures from the IgE values found in untreated cultures .
In some experiments, purified B cells (106/ml) from selected donors were cultured for 10 d with autologous monocytes (2 x 105/ml) and irradiated (2,500 rad), cloned T cells (0 .4 x 106/ml), in the presence or absence of exogenous IL-4 (100 U/ml) . Control cultures were set up with cycloheximide . Culture supernatants were then harvested and assessed by RIA for their IgE content .
RIA for IgE. The assay was performed in flexible flat-bottomed microtiter plates (Cooke Laboratory Products, Alexandria, VA) at room temperature as previously described (3) . The wells were coated with 0 .1 ml of a 1 :1 mixture of purified anti-Fce mAbs (7 .12 and 4 .15 ; a kind gift of A . Saxon, University of California Los Angeles, Los Angeles, CA), 2 Feg/ml in carbonate-bicarbonate buffer, pH 9 .6 . After a 16-h incubation, the wells were washed, blocked with PBS/10 % horse serum (HS) for 2 h, and subsequently washed three times with PBS/1 % HS . 0 .1 ml of culture supernatant or different dilutions of IgE standard (Pharmacia Fine Chemicals) were then added to the wells in triplicate and incubated for 16 h in a humidified chamber. The wells were then washed one time with PBS/1% HS containing 0 .05% Tween 20, twice with PBStl% HS, and finally incubated with 0 .1 ml of Phadebas RAST 125 1-anti-human IgE (ND) (Pharmacia Fine Chemicals) for 6 h . The wells were then washed three times with PBS/1% HS/0 .05% Tween 20, eight times under running distilled water, cut out, and counted in a gamma spectrometer (Tracor Analytic, Elk Grove Village, IL) . The concentrations of IgE in the supernatants were read from the standard curve. The lower limit of sensitivity of this assay is 150 pg/ml. This assay was validated in a recent multicenter collaborative assessment of the variability of IgE measurement in cell culture supernatants (20) .
Results
Requirements for Cellular Interactions in IL-4-dependent IgE Synthesis . Dose-response curve for the effect of rIL-4 on IgE synthesis by human PBMC . Different concentrations of purified human rIL-4 were added to normal PBMC (1 .5 x 10 6 cells/ml) . After 9 d the culture supernatants were harvested and assessed by RIA for their IgE content . The data represent the mean ± SE of three experiments.
timal in the presence of monocytes. IL-5 and IL-6 strongly amplify IgE synthesis. More importantly, endogenous IL-6 is required for IL-4-induced IgE synthesis (17) . Table I shows that a combination of these lymphokines could not induce IgE production by highly purified B cells, even in the presence of powerful polyclonal B cell activators, such as insolubilized anti-g antibodies and SAC. B cells, however, became responsive to IL-4 upon readdition ofT cells. In five experiments with different normal donors, the B/T cell ratio required for substantial induction of IgE synthesis ranged Taken together, these data indicated that the requirement for T cells could not be bypassed by soluble T cell products and suggested that physical interactions between T and B cells might be required for IgE synthesis. This hypothesis was further supported by experiments in which autologous purified T and B cells were cultured in the presence of rIL-4 (100 U/ml), either in the same well or separated by a 0.4-Ftm membrane permeable to protein macromolecules . As shown in Table II, Cell populations (PBMC, purified B cells, or reconstituted autologous T/B cell mixtures : 1 .5 x 106 cells/ml) from normal donors were incubated with medium or rIL-4 + rIL-6 (100 U/ml) . Purified B cells were stimulated with insolubilized anti-,u antibody (1-10 Wg/ml) or SAC (0 .1 %) . Culture supernatants were harvested after 9 d and assessed by RIA for their IgE concentration . Control cultures were set up in the presence of cycloheximide (100 lag/ml) . Net IgE synthesis was determined by subtracting IgE concentrations in cycloheximide-treated cultures from IgE concentrations in untreated cultures . Physical Separation of B from T Cells Prevents IgE Synthesis B cells (0 .6 x 106 cells/culture) from normal donors in complete medium were cultured in 0 .7 ml wells . T cells (1 .2 x 10 6 cells/culture) were cultured either in wells with the B cells or in inserts, separated from B cells by a 0 .4-pm membrane . rIL-4 was added at 100 U/ml . After 9 d the supernatants from wells and inserts were separately harvested and assessed for their IgE content . Net IgE synthesis was evaluated as described in the legend to Table I . thesis requires physical T-B cell interactions, we next asked whether CAMS play a role in such interactions . To this purpose, PBMC from normal donors were incubated with optimal concentrations of rIL-4 (100 U/ml) in the presence of mAbs specific for various CAMS expressed by B cells and/or T cells. As shown in Table  III , anti-CD2 and anti-CD4 mAbs strongly and consistently inhibited IL-4-induced IgE synthesis. Anti-LFA-1 (a chain) mAb had a more variable effect, although in most experiments it inhibited IL-4-induced IgE synthesis. By contrast, no inhibition was observed using anti-CD8 mAb or the pan-T anti-CD7 mAb. These results suggested that CAMS play an important role in the cellular interactions required for IL-4-dependent IgE synthesis.
rnAbs Specificfor the TCR/CD3 Complex andMHC Class II Antigens Inhibit IL-4-induced IgE Synthesis. We next asked whether the TCR/CD3 complex also plays a role in T/B cell interactions required for IL-4-induced IgE synthesis. To this purpose, we Unfractionated normal PBMC (1 .5 x 10 6 cells/ml) were cultured with rIL-4 (100 U/ml), in the presence or absence of mAbs to LFA-1 (IOpg/ml), CD2 (1 Wg/ml), CD4 (2 .5 Kg/ml, CD8 (1 jug/ml), CD7 (3 lug/ml) . After 9 d the culture supernatants were harvested and assessed by RIA for their IgE content . Net IgE synthesis was evaluated as described in the legend to Table I . The mAbs by themselves had no effect on IgE synthesis . Unfractionated normal PBMC (1 .5 x 10 6 cells/ml) were cultured with rIL-4 (100 U/ml), in the presence or absence of anti-CD3 (0 .1 14g/ml), anti-Leu-4 (I jig/ml), or WT-31 (1 Ftg/ml) mAbs . After 9 d the culture supernatants were harvested and assessed by RIA for their IgE content . Net IgE synthesis was evaluated as described in the legend to Table I . studied the effect ofanti-CD3 mAbs on IgE production induced by rIL-4 in normal PBMC. Both OKT3 and anti-Leu-4 inhibited IL-4-dependent IgE synthesis (Table  IV , Exps . 1 and 2), although they induced a strong proliferative response (data not shown) . Inhibition of IgE synthesis by anti-Leu-4 was also observed in the virtual absence of proliferation using PBMC from a "Leu-4 nonresponder" (23) whose monocytes do not express Fc receptors for mouse IgG1 (Table IV, Exp. 3). Thus, anti-CD3 mAbs inhibited IL-4-induced IgE synthesis by PBMC regardless oftheir effect on cell proliferation. Furthermore, IgE synthesis was inhibited by WT31, a mAb specific for a framework determinant of the TCR-a//3 heterodimer (24), which also induced strong cell proliferation (data not shown) .
In parallel, we assessed the role of MHC class II antigens in cell interactions required for IL-4-induced IgE synthesis. As shown in Table V Unfractionated normal PBMC (1 .5 x 10 6 cells/ml) were cultured with rIL-4 (100 U/ml) t rIL-6 (100 U/ml), in the presence or absence of anti-MHC class II (HLA-DR : 2 .5 Wg/ml), anti-MHC class I (1 tag/ml), or anti-CD20 (1 tag/ml) mAbs . After 9 d the culture supernatants were harvested and assessed by RIA for their IgE content . Net IgE synthesis was evaluated as described in the legend to U/ml). Comparable results were obtained using an anti-HLA-DR mAb (OKIal) from a different source (data not shown) . By contrast, mAb specific for MHC class I antigens or the pan-B cell antigen CD20 had no effect . Furthermore, anti-HLA-DR mAb strongly inhibited high-rate IgE synthesis induced by a combination of IL-4 +IL-6. Interestingly, anti-HLA-DR mAb inhibited PBMC proliferation induced by rIL-4, but not by rIL-2 (data not shown) . This suggests that inhibition by anti-HLA-DR mAb did not result from cell toxicity. These results show that the cellular interactions required for IL-4-dependent IgE synthesis are mediated by the TCR/CD3 complex on T cells and MHC class II antigens on B cells, and suggest that cognate T/B cell interactions may be involved in IL-4-driven induction of IgE synthesis.
Cognate T/B Cell Interaction Is Required for IL-4-dependent IgE Synthesis. Although the results of the previous experiments strongly pointed at a role of cognate T/B cell interactions in IL-4-dependent IgE synthesis, we had to consider the possibility that inhibition of IgE production by mAbs to CAMS, MHC class II antigens, and TCR/CD3 complex may result from direct negative signaling to the T and/or B cells. We therefore examined the requirement for T/B cell interactions for IgE induction by alloreactive human T cell clones . To this purpose, we compared the IgE inducing ability of two human IL-4-producing alloreactive T cell clones, F6 and Al, which have different MHC recognition properties.
Clone F6 is a TTspecific T cell clone, which also recognizes HLA-DR4 and produces IL-4, as well as IL-2 and IFN-7 (3, 19) . As shown in Table VI, clone F6 strongly TABLE VI Cognate TIB Cell Interaction Is Required for IL-4-dependent IgE Synthesis Purified B cells (106/ml) from selected normal donors were cultured for 10 d with autologous monocytes (2 x 10 5/ml) and irradiated (2,500 rad), cloned T cells (0 .4 x 106/ml), in the presence or absence of exogenous IL-4 (100 U/ml) . A polyclonal anti-IL-4 antibody was added at 1 :500 . Control cultures were set up with cycloheximide . Culture supernatants were then harvested and assessed by RIA for their IgE content . Net IgE synthesis was evaluated as described in the legend to Table I . Tissue typing of the B cell donors was kindly performed by the HLA laboratory at the Dana Farber Cancer Institute, Boston, MA . Clone F6 and Al showed intense proliferation upon incubation with B cells from donor DL (HLA-DR4* ), but not with cells from donor RC (HLA-DR5' ) . Clone Al recognizes an HLA-DP-associated epitope on monocytes, but not on B cells (26 induced IgE synthesis by purified normal B cells from an HLA-DR4+ allostimulator (DL). IgE production was not further significantly increased by the addition of exogenous IL-4, but was IL-4 dependent, since it was blocked by an anti-IL-4 antibody. By contrast, clone F6 did not induce IgE synthesis from HLA-DR5+ allogeneic B cells (RC) or from HLA-DR3, 5 + autologous B cells (SA; data not shown) . Exogenous IL-4 at high concentrations (100 U/ml) could not restore the IgE-inducing ability of clone F6 in the latter cultures, while it induced a vigorous IgE response by PBMC from all three B cell donors (data not shown) . Thus, the failure of clone F6 to induce IgE production by B cells lacking the relevant alloantigen was not due to the absence ofcirculating B cells potentially able to differentiate into IgE production, nor to the absence of IL-4. Clone A1 is the human equivalent of a murine Th2 clone, in that it secretes IL-4 but not IL-2 or IFN-y (19) . Supernatants from clone A1 induce IgE synthesis by normal PBMC and FcrzR2/CD23 expression on monocytes. Both effects are IL-4 dependent, since they can be inhibited by an anti-IL-4 antibody (12, 25) . Interestingly, clone A1 recognizes an HLA-DP-associated antigen expressed on monocytes, but not on B cells (26) . We therefore incubated clone A1 with monocytes (as stimulator cells) and B cells (as bystander effector cells) from a donor (DL) bearing the appropriate alloantigen . As shown in Table VI , clone A1 did not induce IgE synthesis, although under such conditions the clone strongly proliferates and secretes large amounts of IL-4 (19, 26) . Furthermore, addition ofexogenous IL-4 to cultures of clone A1 and B cells from donor DL did not result in IgE synthesis. As mentioned above, PBMC from donor DL vigorously synthesized IgE upon stimulation with rIL-4, and B cells from the same donor were induced to synthesize IgE in the presence of clone F6 . These results conclusively show that the signal delivered by IL-4 is not sufficient to induce B cells to synthesize IgE; cognate T/B cell recognition is necessary, as well .
Discussion
We have recently shown that the induction of IgE synthesis by IL-4 requires T cells and monocytes, as well as T cell-and monocyte-derived cytokines (17) . Optimal cytokine combinations, however, fail to induce highly purified B cells to secrete IgE, indicating that additional signals are necessary. Our results now show that IL-4-dependent IgE synthesis by circulating B cells requires cognate interaction between the TCR/CD3 complex on T cells and MHC class II antigens on B cells, as well as the contribution of cell adhesion molecules, as determined by the ability of mAbs directed against these structures to block IgE synthesis induced by IL-4, and by the MHC class II-restricted IgE-inducing ability of IL-4-producing alloreactive T cell clones. The observation that anti-MHC class II, but not anti-MHC class I, mAbs inhibited IL-4-dependent IgE synthesis is consistent with the finding that anti-CD4 mAb, but not anti-CD8 mAb, blocked IgE production, and indicates that a CD4+ helper T cell subset is involved in B cell recognition. In future experiments we will attempt a further phenotypic and functional characterization of the T cell population(s) involved in the T cell-dependent induction of IgE synthesis .
We considered the possibility that inhibition of IL-4-induced IgE synthesis by the various antibodies used in this study resulted from direct negative signaling to the B and/or T cells, rather than from interference with T/B cell recognition . Anti-HLA-DR mAbs, including L243, are known to directly inhibit B cell activation, particularly in its early steps (27, 28) . At the T cell level, antibodies to CD2, CD4, and LFA-1 can inhibit signal transduction, thus blocking T cell functions (29) (30) (31) (32) . It is, however, unlikely that the inhibition of IgE synthesis results from direct negative signals to the T and/or B cells, because inhibition of IgE synthesis by antiTCR and anti-CD3 mAbs occurred in spite ofthe induction ofvigorous T cell proliferation.
To completely rule out the negative-signal hypothesis, we used an experimental system in which normal B cells are stimulated to produce IgE by IL-4-producing alloreactive T cell clones . Such a system, in which no external stimuli can deliver direct negative signals to the T and/or B cells, is only constrained by T/B cell recognition . Clone F6, which recognizes MHC class Il antigens expressed on both B cells and monocytes (26) Interestingly, clone F6 induced IgE synthesis by B cells in spite of its ability to secrete high amounts of IFN-y. These results are in apparent contrast with previous reports describing the inhibitory effect on human IgE production by IFN-y contained in the supernatant of alloreactive T cell clones producing both IFN-y and IL-4 (13, 16) . In those reports, however, the responding B cells were not engaged in direct cognate interaction with the T cell clones . Since cognate interaction has been shown to play a crucial role in focusing the release ofT cell-derived lymphokines (and in particular, IL-4) at the area in which the TCR is crosslinked by the antigen (33, 34) , direct T/B cell recognition, in the presence ofendogenously secreted IL-4, may deliver to the B cells an activating signal sufficient (and necessary) to bypass the inhibitory effect of IFN-y. Furthermore, experiments in the murine system (in which IL-4 typically induces IgE and IgG1 [7] ) have shown that the addition of IL-4 to cultures containing a TNP-specific Thl clone (producing IFN-'v but not IL-4) resulted in the production of IgG1 antiTNP by TNP-specific B cells (35) . These data indicate that IL-4 responsiveness can be retained in the presence of IFN-y in systems that involve T/B cognate interaction .
Taken together, our results suggest that at least two signals are involved in the T cell-dependent triggering of IgE production by B cells : one signal is delivered by T cells recognizing MHC class II antigens on B cells, the other by T cell-derived IL-4. These two signals are likely to synergize in the activation of B cells into IgE production . IL-4 stimulation ofB cells, which bear IL-4 receptors even in their resting state (36, 37) , increases MHC class II antigens density by 5-to 10-fold (38) . An increased density of MHC class II antigens on B cells may enhance their capacity to activate a subset ofT cells recognizing autologous MHC class II antigens + self peptides (5, 39), or + foreign peptides . In our experimental system, foreign peptides may be derived from the bovine serum . The interaction between TCR and their targets described here seems to have a low affinity, since it is critically dependent on accessory molecules (40) .
Thus IL-4 would, on the one hand enhance T/B cognate recognition, and on the other hand, drive the B cell response towards the IgE isotype, acting as an IgE-switching factor (41) (42) (43) . IfT/B cell recognition in the presence of IL-4 is necessary and sufficient to induce IgE synthesis, we would predict that IL-4-dependent IgE production should occur also in allogeneic T/B cell mixtures, as a result of the activation of a subset of T cells able to recognize MHC class II antigens expressed on the allogeneic B cells. Experiments currently in progress in our laboratory indicate that this is indeed the case (Vercelli, D., H. H. Jabara, and R. S. Geha, unpublished observation) .
Summary
The induction of IgE synthesis by IL-4 requires T cells and monocytes, as well as T cell-and monocyte-derived cytokines . Optimal cytokine combinations, however, fail to induce highly purified B cells to secrete IgE, indicating that additional signals are required. We show herein that the induction of human IgE synthesis by rIL-4 requires cognate interaction between the T cell receptor/CD3 complex on T cells and MHC class 11 antigens on B cells : mAbs directed against these molecules completely blocked IL-4-dependent IgE induction . mAbs against cell adhesion molecules (CD2, CD4, LFA-1) also inhibited IgE synthesis induced by IL-4, confirming that cell-cell contact is necessary for IgE induction . The requirement for cognate T/B cell interaction was further shown by comparing the IgE-inducing ability of two human IL-4-producing alloreactive T cell clones : F6, which recognizes MHC class II antigens on both B cells and monocytes, and Al, which recognizes an HLA-DPassociated epitope expressed on monocytes, but not on B cells . When incubated with B cells and monocytes from a normal donor bearing the appropriate alloantigen, clone F6, but not clone Al, induced vigorous IgE synthesis, although both clones proliferated and secreted IL-4 . Taken together, our results suggest that at least two, possibly synergizing, signals are required for the T cell-dependent induction of IgE synthesis by B cells : one signal is delivered by cognate T/B cell interaction, the other by T cell-derived IL-4.
